|
EGIS Pharmaceuticals Public Limited Company - Company Profile Snapshot
| Supplementary Analyses Reports |
| Financial Statement Analysis |
| Balance Sheet & Income Statement: |
| Common Size |
| Year To Year Percent Change |
| 5 Year Averages |
| Sources Of Capital |
| Financial Ratio Analysis |
| Accounting Ratios |
| Asset Utilization |
| Employee Efficiency |
| Fixed Charges Coverage |
| Leverage Analysis |
| Liquidity Analysis |
| Per Share Data |
| Profitability Analysis |
| Wright Quality Rating |
| Investment Acceptance |
| Financial Strength |
| Profitability & Stability |
| Corporate Growth |
 View sample Supplementary Analyses (PDF)
|
| Company Profile: |
EGIS Pharmaceuticals Public Limited Company |
| Ticker: |
EGIS |
| Exchanges: |
BUD |
| 2007 Sales: |
117,180,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
HUNGARY |
| Employees: |
2619 |
Business Description
EGIS Pharmaceuticals Public Limited Company. The Group's principal activity is production and sale of pharmaceutical raw materials and finished goods. It operates in two segments: Production and realization of pharmaceutical products and Wholesale and retail of medicines. The Group operates in the following geographical segments: Hungary, European Union, Other European countries, North America and Japan and Other. The Group founded two new subsidiaries EGIS Bulgaria EOOD in Bulgaria and EGIS Rompharma in Romania
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
